Accretion Nutrav

Not Rated
  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE1KVQ01019
  • NSEID:
  • BSEID: 544694
INR
290.00
-13 (-4.29%)
BSENSE

Oct 09

BSE+NSE Vol: 1000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 110.00% vs NA in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 85.14% vs NA in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 50.52% vs NA in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is 102.66% vs NA in Mar 2025

Compare Profit and Loss Results of Accretion Nutrav
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
33.00
225.00
-192.00
-85.33%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
29.00
-29.00
-100.00%
Net Sales
33.00
196.00
-163.00
-83.16%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
-1.00
1.00
100.00%
Raw Materials Consumed
25.00
125.00
-100.00
-80.00%
Power & Fuel Cost
0.00
12.00
-12.00
-100.00%
Employee Cost
1.00
15.00
-14.00
-93.33%
Operating Expenses
0.00
12.00
-12.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
4.00
-4.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
2.00
-2.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
26.00
176.00
-150.00
-85.23%
Operating Profit (PBDIT) excl Other Income
6.00
19.00
-13.00
-68.42%
Other Income
0.00
1.00
-1.00
-100.00%
Operating Profit (PBDIT)
7.00
21.00
-14.00
-66.67%
Interest
0.00
6.00
-6.00
-100.00%
Profit before Depriciation and Tax
6.00
14.00
-8.00
-57.14%
Depreciation
0.00
6.00
-6.00
-100.00%
Profit Before Taxation & Exceptional Items
6.00
8.00
-2.00
-25.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
6.00
8.00
-2.00
-25.00%
Provision for Tax
1.00
2.00
-1.00
-50.00%
Profit After Tax
5.00
5.00
0.00
0.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
3.00
31.00
-28.00
-90.32%
Profit Available for appropriations
8.00
36.00
-28.00
-77.78%
Appropriations
8.00
36.00
-28.00
-77.78%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
9.35
5.7
3.65
64.04%
Profit And Loss - Net Sales
Net Sales 33.60 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 110.00% vs NA in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 6.89 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 85.14% vs NA in Mar 2025

Profit And Loss - Interest
Interest 0.53 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 50.52% vs NA in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 5.07 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 102.66% vs NA in Mar 2025